Does dose rate affect efficacy? The outcomes of 256 Gamma Knife surgery procedures for trigeminal neuralgia and other types of facial pain as they relate to the half-life of cobalt

Restricted access

Object

Gamma Knife surgery (GKS) is a treatment option for patients with refractory typical trigeminal neuralgia (TN), TN with atypical features, and atypical types of facial pain. The Gamma Knife’s 201 60Co sources decay with a half-life of 5.26 years. The authors examined whether the decrease in dose rate over 4.6 years between Co source replacements affected the control rates of facial pain in patients undergoing GKS.

Methods

The authors collected complete follow-up data on 239 of 326 GKS procedures performed in patients with facial pain. Patients were classified by their type of pain. The isocenter of a 4-mm collimator helmet was targeted at the proximal trigeminal nerve root, and the dose (80–90 Gy) was prescribed at the 100% isodose line. Patients reported the amount of pain control following radiosurgery by answering a standardized questionnaire.

Eighty percent of patients experienced greater than 50% pain relief, and 56% of patients experienced complete pain relief after GKS. Neither dose rate nor treatment time was significantly associated with either the control rate or degree of pain relief. A significant association between the type of facial pain and the pain control rate after GKS was observed (p < 0.001; Pearson chi-square test).

In their statistical analysis, the authors accounted for changes in prescription dose over time to prevent the dose rate from being a confounding variable. There was no observable effect of the dose rate or of the treatment duration within the typical period to source replacement.

Conclusions

Patients with facial pain appear to receive consistent treatment with GKS at any time during the first half-life of the Co sources.

Abbreviations used in this paper:BED = biologically effective dose; GKS = Gamma Knife surgery; TN = trigeminal neuralgia.

Article Information

Address reprint requests to: Volker W. Stieber, M.D., Department of Radiation Oncology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157-1030. email: vstieber@wfubmc.edu.

© AANS, except where prohibited by US copyright law.

Headings

Figures

  • View in gallery

    Line graph demonstrating the time to pain recurrence in the patients who experienced complete pain relief.

  • View in gallery

    Scatterplot showing the dose levels prescribed over the course of the study. Each circle represents a patient. Q = quarter.

  • View in gallery

    Scatterplot showing the increase in treatment duration over the course of the study.

  • View in gallery

    Graph showing the relationship of the calculated BED to the dose rate for the three most commonly used prescription doses.

References

  • 1

    Alpert TEChung CTMitchell LTHodge CJMontgomery CTBogart JA: Gamma knife surgery for trigeminal neuralgia: improved initial response with two isocenters and increasing dose. J Neurosurg 102:Suppl1851882005

  • 2

    Brisman RKhandji AGMooij RB: Trigeminal nerve-blood vessel relationship as revealed by high-resolution magnetic resonance imaging and its effect on pain relief after gamma knife radiosurgery for trigeminal neuralgia. Neurosurgery 50:126112662002

  • 3

    Brisman RMooij R: Gamma knife radiosurgery for trigeminal neuralgia: dose-volume histograms of the brainstem and trigeminal nerve. J Neurosurg 93:Suppl 31551582000

  • 4

    Burchiel KJ: A new classification for facial pain. Neurosurgery 53:116411672003

  • 5

    Chen AC: New perspectives in EEG/MEG brain mapping and PET/fMRI neuroimaging of human pain. Int J Psychophysiol 42:1471592001

  • 6

    Coghill RCMcHaffie JGYen YF: Neural correlates of interindividual differences in the subjective experience of pain. Proc Natl Acad Sci U S A 100:853885422003

  • 7

    Flickinger JCPollock BEKondziolka DPhuong LKFoote RLStafford SL: Does increased nerve length within the treatment volume improve trigeminal neuralgia radiosurgery? A prospective double-blind, randomized study. Int J Radiat Oncol Biol Phys 51:4494542001

  • 8

    Katusic SWilliams DBBeard CMBergstralh EKurland LT: Incidence and clinical features of glossopharyngeal neuralgia, Rochester, Minnesota, 1945–1984. Neuroepidemiology 10:2662751991

  • 9

    Leksell L: Sterotaxic radiosurgery in trigeminal neuralgia. Acta Chir Scand 137:3113141971

  • 10

    Nilsson PThames HDJoiner MC: A generalized formulation of the ‘incomplete-repair’ model for cell survival and tissue response to fractionated low dose-rate irradiation. Int J Radiat Biol 57:1271421990

  • 11

    Orton CGCohen L: A unified approach to dose-effect relationships in radiotherapy. I: Modified TDF and linear quadratic equations. Int J Radiat Oncol Biol Phys 14:5495561988

  • 12

    Pollock BEPhuong LKFoote RLStafford SLGorman DA: High-dose trigeminal neuralgia radiosurgery associated with increased risk of trigeminal nerve dysfunction. Neurosurgery 49:58642001

  • 13

    Shigematsu NKunieda EKawaguchi OTakeda AIhara NYamashita S: Indications of stereotactic irradiation for brain lesions. Acta Oncol 39:5976032000

  • 14

    Testa TNahum MASpinelli ECarbone EFlocchini GPMotta G: The “Will Rogers effect” on stage grading. Ann Ital Chir 70:8298301999

  • 15

    Thames HD: An ‘incomplete-repair’ model for survival after fractionated and continuous irradiations. Int J Radiat Biol Relat Stud Phys Chem Med 47:3193391985

  • 16

    Wigg DR: A radiobiological basis for the treatment of arteriovenous malformations. Acta Oncol 38:Suppl 143291999

  • 17

    Yu CLuxton GApuzzo MLPetrovich Z: TLD measurements of the relative output factors for the Leksell Gamma Knife. Stereotact Funct Neurosurg 72:Suppl 11501581999

TrendMD

Cited By

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 165 165 99
Full Text Views 122 122 0
PDF Downloads 103 103 1
EPUB Downloads 0 0 0

PubMed

Google Scholar